余 仙,赵和照.MMR/MSI在Ⅱ/Ⅲ期结直肠癌辅助化疗[J].中国肿瘤,2016,25(12):994-998. |
MMR/MSI在Ⅱ/Ⅲ期结直肠癌辅助化疗 |
Progress on MMR/MSI in Adjuvant Chemotherapy for Colorectal Cancer Stage Ⅱ/Ⅲ |
投稿时间:2015-05-30 |
DOI:10.11735/j.issn.1004-0242.2016.12.A010 |
|
 |
中文关键词: 结直肠癌 化疗 错配修复系统 微卫星不稳定性 |
英文关键词:colorectal cancer chemotherapy mismatch repair microsatellite instability |
基金项目: |
|
摘要点击次数: 1983 |
全文下载次数: 740 |
中文摘要: |
摘 要:微卫星稳定性作为评价DNA错配修复系统(MMR)的功能标记,可作为Ⅱ期和Ⅲ期结直肠癌患者辅助治疗的风险评估有效工具。全文从错配修复基因/微卫星不稳定性与结直肠癌发生及其在Ⅱ/Ⅲ期结肠癌化疗辅助治疗中的应用方面进行综述。 |
英文摘要: |
Abstract:Stability of microsatellite as a functional marker for evaluation of DNA mismatch repair (MMR) system,was used as an effective tool for the risk evaluation of adjuvant treatment of patients with colorectal cancer stage Ⅱ and Ⅲ. The correlation between MMR/MSI and colorectal cancer,and the application of MMR/MSI in adjuvant chemotherapy for colorectal cancer stage Ⅱ/Ⅲ were reviewed. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |